AARD
Aardvark Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Aardvark Therapeutics (AARD) Stock: Buy, Sell, or Hold?
$1.33
-0.19 (-12.50%)
âŧ
5d:
+13.68%
30d:
-65.54%
90d:
-80.27%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (72%)
Quality Score
49/100
Position
SLIGHTLY LOW
30-Day Fair Range
$1.19 â $4.27
Position: SLIGHTLY LOW
Forward P/E & Valuation
-0.6x
Next 12M consensus est.
Wall Street Target
$4.57
+243.7% upside
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$1.09 / $1.70
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: AARD is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When AARD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: AARD is currently trading at $1.33, which is considered slightly low relative to its 30-day fair value range of $1.19 to $4.27.
Technical Outlook: Technically, AARD is in a strong downtrend. Immediate support is located at $1.09, while resistance sits at $1.70. Short-term momentum is weak, with the stock down 12.5% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.57 (+243.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AARD is in a strong downtrend. Immediate support is located at $1.09, while resistance sits at $1.70. Short-term momentum is weak, with the stock down 12.5% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.57 (+243.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.19 -
$4.27
Company Quality Score
49/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
72.1%
Trading Range & Key Levels
30-Day Trading Range
$1.19 -
$4.27
Current vs Trading Range
SLIGHTLY LOW
Support Level
$1.09
Resistance Level
$1.70
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (58/100)
- BEARISH: Downward momentum (-12.5%)
- BULLISH: Trading 243.7% below Wall St target ($4.57)
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.58
Wall Street Target
$4.57
(+243.7%)
Share AARD Analysis
Share this live AARD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (AARD)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits is filled with bullish sentiment towards $AARD as traders anticipate earnings and potential new news.
Key Retail Themes:
Earnings Expectations
Potential New News
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:28 PM ET
Data refreshes hourly during market hours. Next update: 6:28 PM
Data refreshes hourly during market hours. Next update: 6:28 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AARD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
28 analysts |
$91 | 54 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 45 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 42 HOLD |
|
RAPP
Rapport Therapeutics, InâĻ |
STRONG BUY
16 analysts |
$64 | 49 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive AARD Research Pages
